Lindsay Mueller, PA
Medical · Indianapolis, INNPI 1841720653
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 437 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,826 and has fallen 52.4% since, to $1,345 in 2025. Among medical clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Johnson & Johnson$1K
- Gilead$366
- Regeneron Healthcare Solutions, Inc.$282
- plus $2K from 30 others
What the payments were for
- Food & beverage$9,05699%
- Education$891%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 96 | $2,113 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 81 | $1,721 |
| Takeda Pharmaceuticals U.S.A., Inc. | 80 | $1,605 |
| Johnson & Johnson | 53 | $1,018 |
| Gilead | 17 | $366 |
| Regeneron Healthcare Solutions, Inc. | 13 | $282 |
| Phathom Pharmaceuticals, Inc. | 9 | $242 |
| Sanofi | 6 | $223 |
| Ardelyx, Inc. | 10 | $183 |
| Merck | 9 | $164 |
| Lilly USA, LLC | 6 | $106 |
| Pfizer | 6 | $95 |
| Nestle Healthcare Nutrition Inc. | 5 | $89 |
| Ironwood Pharmaceuticals, Inc | 5 | $83 |
| Ipsen Biopharmaceuticals, Inc | 4 | $77 |
| Madrigal Pharmaceuticals | 3 | $75 |
| Celltrion USA Inc. | 4 | $75 |
| Intercept Pharmaceuticals, Inc. | 3 | $56 |
| QOL Medical, LLC | 3 | $53 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| Mauna Kea Technologies, Inc. | 2 | $48 |
| Organon | 2 | $46 |
| Braintree Laboratories, Inc. | 2 | $40 |
| AstraZeneca | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Sandoz | 2 | $36 |
| Redhill Biopharma Inc. | 1 | $30 |
| Laborie Medical Technologies Corp. | 1 | $28 |
| Eisai Inc. | 1 | $25 |
| Boston Scientific | 1 | $24 |
| Medtronic | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,144 in reported general payments places this provider in the 90th percentile of 273 medical providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| StelaraUstekinumab | 13 | $354,857 |
| CreonLipase/Protease/Amylase | 27 | $92,138 |
| LinzessLinaclotide | 71 | $77,636 |
| RelistorMethylnaltrexone Bromide | 17 | $58,337 |
| IbsrelaTenapanor Hcl | 13 | $47,446 |
| MotegrityPrucalopride Succinate | 13 | $17,666 |
| Dexlansoprazole DrDexlansoprazole | 30 | $9,004 |
| Mesalamine | 15 | $7,331 |
| Budesonide EcBudesonide | 13 | $6,865 |
| Omeprazole | 403 | $6,819 |
| Colestipol Hcl | 94 | $5,935 |
| Pantoprazole Sodium | 305 | $4,779 |
| Lubiprostone | 46 | $4,616 |
| Esomeprazole Magnesium | 53 | $4,314 |
| Budesonide DrBudesonide | 16 | $3,476 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonStelara | $1,018 | $354,85713 claims |
| AbbVieCreon, Linzess | $2,113 | $169,77498 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,721 | $58,33717 claims |
| Ardelyx, Inc.Ibsrela | $183 | $47,44613 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $1,605 | $17,66613 claims |
| SandozLansoprazole | $36 | $1,44045 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 273 medical providers in Indiana.
Other medical in Indianapolis
- Meggie BeckleyIndianapolis$125K
- Jennifer ConnerIndianapolis$98K
- Jennifer IrwinIndianapolis$34K
- Andrew BurnsIndianapolis$13K
- Bridget WilliamsonIndianapolis$11K
- Meredith SlayterIndianapolis$8K
- Chelsea WilsonIndianapolis$5K
- Rachel SandersonIndianapolis$4K
- Ryan StromIndianapolis$4K
- Amanda EckhardtIndianapolis$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.